120 related articles for article (PubMed ID: 25915077)
1. Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial.
Vehapoglu A; Ustabas F; Ozgen TI; Terzioglu S; Cermik BB; Ozen OF
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1065-71. PubMed ID: 25915077
[TBL] [Abstract][Full Text] [Related]
2. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
[TBL] [Abstract][Full Text] [Related]
3. The role of the adipocytokines vaspin and visfatin in vascular endothelial function and insulin resistance in obese children.
Yin C; Hu W; Wang M; Xiao Y
BMC Endocr Disord; 2019 Nov; 19(1):127. PubMed ID: 31771561
[TBL] [Abstract][Full Text] [Related]
4. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
[TBL] [Abstract][Full Text] [Related]
5. New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid.
Meral C; Cekmez F; Vurucu S; Tascılar E; Pirgon O; Canpolat FE; Ipcioglu OM; Aydemir G; Aydınoz S
Eur Cytokine Netw; 2011 Jun; 22(2):118-22. PubMed ID: 21669562
[TBL] [Abstract][Full Text] [Related]
6. Association of serum vaspin, apelin, and visfatin levels and stroke risk in a Chinese case-control study.
Yu D; Huang B; Wu B; Xiao J
Medicine (Baltimore); 2021 Mar; 100(12):e25184. PubMed ID: 33761698
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis.
Kadoglou NP; Fotiadis G; Lambadiari V; Maratou E; Dimitriadis G; Liapis CD
Peptides; 2014 Jul; 57():12-6. PubMed ID: 24768795
[TBL] [Abstract][Full Text] [Related]
8. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
[TBL] [Abstract][Full Text] [Related]
9. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of novel adipocytokines in patients with colorectal cancer.
Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
[TBL] [Abstract][Full Text] [Related]
11. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
[TBL] [Abstract][Full Text] [Related]
12. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
[TBL] [Abstract][Full Text] [Related]
13. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
Pazgan-Simon M; Kukla M; Zuwała-Jagiełło J; Derra A; Bator M; Menżyk T; Lekstan A; Grzebyk E; Simon K
PLoS One; 2020; 15(1):e0227459. PubMed ID: 31935230
[TBL] [Abstract][Full Text] [Related]
14. Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure.
Liakos CI; Sanidas EA; Perrea DN; Grassos CA; Chantziara V; Viniou NA; Barbetseas JD; Papadopoulos DP
Am J Hypertens; 2016 May; 29(5):549-52. PubMed ID: 26276791
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study.
Kadoglou NP; Gkontopoulos A; Kapelouzou A; Fotiadis G; Theofilogiannakos EK; Kottas G; Lampropoulos S
Clin Chim Acta; 2011 Jan; 412(1-2):48-52. PubMed ID: 20850423
[TBL] [Abstract][Full Text] [Related]
17. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis.
Machura E; Szczepanska M; Ziora K; Ziora D; Swietochowska E; Barc-Czarnecka M; Kasperska-Zajac A
Mediators Inflamm; 2013; 2013():760691. PubMed ID: 23476106
[TBL] [Abstract][Full Text] [Related]
19. Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans.
Kang ES; Magkos F; Sienkiewicz E; Mantzoros CS
Eur J Endocrinol; 2011 Jun; 164(6):911-7. PubMed ID: 21422197
[TBL] [Abstract][Full Text] [Related]
20. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
